Sernova Biotherapeutics Inc (FRA:PSH0)

Market Cap	35.75M
Revenue (ttm)	n/a
Net Income (ttm)	-18.71M
Shares Out	n/a
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,565
Average Volume	15,890
Open	0.1080
Previous Close	0.1240
Day's Range	0.1080 - 0.1440
52-Week Range	0.0800 - 0.2698
Beta	n/a
RSI	39.47
Earnings Date	Jun 11, 2025

About Sernova Biotherapeutics

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. The comoany was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is headquartered...

• Industry: Biological Products, Except Diagnostic Substances
• CEO: Jonathan M. Rigby
• Employees: 17
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PSH0

Financial Performance

Financial numbers in CAD